Table 1 Patient characteristics, entire cohort.
Number of Patients (%) | ||||
|---|---|---|---|---|
All Patients N = 183 (100) | Black Patients N = 96 (52.5) | White Patients N = 87 (47.5) | P-Value | |
Distant Recurrence | 0.07 | |||
Yes | 77 (42.1) | 47 (49) | 30 (34.5) | |
No | 106 (57.9) | 49 (51) | 57 (65.5) | |
Age | 0.69 | |||
Mean [SD] | 51.9 [11.5] | 51.6 [10.3] | 52.3 [12.7] | |
Median [IQR] | 52 [44, 60] | 51 [45.8, 58.2] | 52 [43.5, 61] | |
Range | 28–95 | 29–78 | 28–95 | |
Time to Distant Recurrence, Months | 0.62 | |||
Mean [SD] | 61.9 [40.4] | 63.9 [42.9] | 59.8 [37.7] | |
Median [IQR] | 62.5 [26.1, 92.9] | 60.7 [26.6, 94.3] | 64 [25.8, 89.5] | |
Range | 1–160.7 | 9.4–159.8 | 1–160.7 | |
Surgery | 0.04 | |||
Mastectomy | 114 (62.3) | 67 (69.8) | 47 (54) | |
Breast-Conserving Therapy | 69 (37.7) | 29 (30.2) | 40 (46) | |
Tumor Stage (ypT) | 0.84 | |||
T1 ( < 2 cm) | 82 (44.8) | 45 (46.9) | 37 (42.5) | |
T2 (2–5 cm) | 71 (38.8) | 36 (37.5) | 35 (40.2) | |
T3 ( > 5 cm) | 30 (16.4) | 15 (15.6) | 15 (17.2) | |
Lymph Node Status (ypN) | 0.67 | |||
Positive | 130 (71) | 70 (72.9) | 60 (69) | |
Negative | 53 (29) | 26 (27.1) | 27 (31) | |
Grade | 0.002 | |||
1 | 6 (3.3) | 0 (0) | 6 (6.9) | |
2 | 50 (27.3) | 22 (22.9) | 28 (32.2) | |
3 | 119 (65) | 73 (76) | 46 (52.9) | |
Unknown | 8 (4.4) | 1 (1) | 7 (8) | |
Subtype | 0.1 | |||
ER+/HER2- | 91 (49.7) | 41 (42.7) | 50 (57.5) | |
TNBC | 59 (32.2) | 37 (38.5) | 22 (25.3) | |
Other | 33 (18) | 18 (18.8) | 15 (17.2) | |
